Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.
about
Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potentialTracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot studyThe current 'state of play' of regenerative medicine in horses: what the horse can tell the human.Use of contrast media in computed tomography and magnetic resonance imaging in horses: Techniques, adverse events and opportunities.Mesenchymal stem cells for tendon healing: what is on the horizon?Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal liScintigraphic comparison of intra-arterial injection and distal intravenous regional limb perfusion for administration of mesenchymal stem cells to the equine foot.Scintigraphic tracking of mesenchymal stem cells after intravenous regional limb perfusion and subcutaneous administration in the standing horse.MRI-Based Assessment of Intralesional Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in a Model of Equine Tendonitis.Morphine Synovial Fluid Concentrations After Intravenous Regional Limb Perfusion in Standing Horses.Superparamagnetic iron oxide nanoparticles as a means to track mesenchymal stem cells in a large animal model of tendon injury.Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.Morphine Synovial Fluid Concentrations After Intravenous Regional Limb Perfusion in Standing Horses.Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs.Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging.Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy.In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy.Scintigraphic Tracking of Allogeneic Mesenchymal Stem Cells in the Distal Limb After Intra-Arterial Injection in Standing Horses.Ultrasound-guided injection of the median artery in the standing sedated horse.The Contribution of Adipose Tissue-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma to the Treatment of Chronic Equine Laminitis: A Proof of Concept.Influence of commonly used pharmaceutical agents on equine bone marrow-derived mesenchymal stem cell viability.In vivo tracking and fate of intra-articularly injected superparamagnetic iron oxide particle-labeled multipotent stromal cells in an ovine model of osteoarthritis.Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells.Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.Fate of mesoangioblasts in a vaginal birth injury model: influence of the route of administration
P2860
Q33746230-F4CC3302-102B-4F78-B71E-EAEFE51AC5B2Q36529899-2F0ACBDD-D7C2-466E-B775-AB399B6428E5Q38265208-392CFCA4-0E28-4173-942B-C93284B35E85Q38838147-B91D5340-5015-4257-AF11-0AA3D9FFE4DFQ38946911-1583D1D7-B1A1-40DA-AACB-644C78ACC409Q39150444-71F9E545-FBA1-4316-89DA-798C1EE9931AQ40104265-1B3AEBDA-8A94-4F39-8428-FE37FFDDAFD5Q40122747-DE06D1E4-97D1-4D9F-8B50-F9710206EB8AQ40228263-968D88ED-130C-4AC1-B623-E14BCACA2E9BQ40413142-A303139E-7983-4AB3-BC03-2AB48D4EA84EQ40680997-E1E5F00F-907C-4DC2-AD85-C0A6E2B03F1DQ40879659-C3B575B2-D743-444B-86E6-7CA036BD1DEBQ41060784-58998BE1-6AA2-4448-AAD6-C6D8623798A1Q41554917-E852B482-9542-44C7-88C2-581E836B82EAQ41591175-2F7D7126-ABA3-42EC-9F9F-9223A4FE3BD3Q41842512-4896CB35-FE10-492A-9823-9E58E014D572Q44930596-45B3268F-E497-4482-907F-55179E55F6D7Q45939031-7376D04B-BC55-4D57-A54A-4F77A3A46017Q46006623-15DDF509-A622-49CD-996E-854FF29309E6Q46076100-E2C3C3A8-F504-441D-B274-5EEEEDAFD05BQ47158525-A32CF480-780E-4844-AE02-90445FBCD488Q47432788-146EF115-0923-45E1-B31E-587281D36FC8Q48693282-D156380B-F4D9-4C7A-A01A-1E2535E86C44Q50950707-2257FC47-E0C2-47A8-B082-601F8E7AF169Q55091426-BE9D03CA-704B-41F0-A8C3-3720875DCEFEQ57248351-174BBF17-73E3-4A82-A5D1-2A16FD41A36F
P2860
Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Scintigraphic evaluation of in ...... tal limb using (99m) Tc-HMPAO.
@en
Scintigraphic evaluation of in ...... ormal equine distal limb using
@nl
type
label
Scintigraphic evaluation of in ...... tal limb using (99m) Tc-HMPAO.
@en
Scintigraphic evaluation of in ...... ormal equine distal limb using
@nl
prefLabel
Scintigraphic evaluation of in ...... tal limb using (99m) Tc-HMPAO.
@en
Scintigraphic evaluation of in ...... ormal equine distal limb using
@nl
P2093
P2860
P1476
Scintigraphic evaluation of in ...... tal limb using (99m) Tc-HMPAO.
@en
P2093
D L Borjesson
E R Wisner
K A Padgett
L D Galuppo
R J Brosnan
P2860
P304
P356
10.1111/J.2042-3306.2011.00530.X
P50
P577
2011-12-30T00:00:00Z